Christoph Ahlgrim

Dr. Christoph Ahlgrim

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
CAChristoph Ahlgrim
Christoph Ahlgrim
MGMaya Guglin
Maya Guglin

14 March 2015 in Allergo Journal International
Verified
Journal Article
Open access
PDF file
JHJohannes Huss-Marp
Johannes Huss-Marp
JGJan Gutermuth
Jan Gutermuth
ISIna Schäffner
Ina Schäffner
UDUlf Darsow
Ulf Darsow
FPFlorian Pfab
Florian Pfab
CAChristoph Ahlgrim
Christoph Ahlgrim
ImmunoCAP ISAC 112, is a commercially available molecular allergy IgE multiplex test. Data on the comparison of this rather novel test with extract-based as well as molecular ImmunoCAP singleplex IgE tests is missing. To perform a comparison between the ISAC multiplex IgE assay and the ImmunoCAP singleplex test results. Serum samples of 101 adults with grass pollen allergy were analysed for sIgE to 112 allergenic molecules represented on the ISAC test as well as to common atopy-related extract-based allergy tests with the ImmunoCAP System (house dust mite [d1], cat [e1], dog [e5], cow’s milk [f2], hen’s egg [f1], hazelnut [f17], celery [f85], Alternaria alternate [m6], as well as pollen from birch [t3], hazel [t4], mugwort [w6], and ragweed [w1]). Subsequently statistical analysis was performed with the Spearman rank correlation test and the Clopper-Pearson method in order to compare the ISAC multiplex results with the sIgE singleplex results. The positive percent agreements (PPA) and negative percent agreement (NPA) of corresponding allergens between the ISAC sIgE test and the extract-based singleplex ImmunoCAP results at cutoff 0.1 kUA/l varied between 60–100 % for PPA and 78–97 % for NPA. When taking into account corresponding allergens molecular testing with the ISAC multiplex test correlates well with ImmunoCAP singleplex results.

23 August 2010 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
CAChristoph Ahlgrim
Christoph Ahlgrim
TPT. Pottgiesser
T. Pottgiesser
NRN. Robinson
N. Robinson
PSP. E. Sottas
P. E. Sottas
GRG. Ruecker
G. Ruecker
YSY. O. Schumacher
Y. O. Schumacher

5 July 2007 in International Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
YSY. O. Schumacher
Y. O. Schumacher
TPT. Pottgiesser
T. Pottgiesser
CAChristoph Ahlgrim
Christoph Ahlgrim
SRS. Ruthardt
S. Ruthardt
HDH.-H. Dickhuth
H.-H. Dickhuth
KRK. Roecker
K. Roecker
Haemoglobin mass is a main determinant of maximal oxygen uptake. Blood doping aims at increasing this variable. Limits for haematocrit and haemoglobin concentration are used as indicators of blood doping. However, these variables are measures of concentration, do not represent total haemoglobin mass and are altered by vascular volumes shifts. Direct estimation of haemoglobin mass could improve blood tests. It is unknown if physical exercise alters haemoglobin mass. The purpose of this study was to investigate the reaction of haemoglobin mass and other vascular compartments to heavy exercise in athletes. Haemoglobin mass and vascular compartments were evaluated using the optimised CO rebreathing method in 7 elite cyclists during a stage race. Simultaneously, haemoglobin concentration and haematocrit were analysed. Haemoglobin mass (pre-race 958 ± 123 g, end race 948 ± 106 g) and red cell volume did not change significantly over the study period, while plasma volume and blood volume tended to increase. Haematocrit (pre-race 44.1 ± 2.5 %, end race 40.9 ± 1.59 %) and haemoglobin concentration (pre race 15.8 ± 0.9 g/dl, end race 14.7 ± 0.7 g/dl) decreased. During the study, a plasma volume expansion as adaptation to prolonged exercise occurred. Haemoglobin concentration and haematocrit decreased accordingly, whereas haemoglobin mass remained stable. Haemoglobin mass might therefore be a suitable screening tool for blood manipulations.

1 October 2007 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
TPTorben Pottgiesser
Torben Pottgiesser
MUMarkus Umhau
Markus Umhau
CAChristoph Ahlgrim
Christoph Ahlgrim
SRSebastian Ruthardt
Sebastian Ruthardt
KRKai Roecker
Kai Roecker
YSYorck Olaf Schumacher
Yorck Olaf Schumacher
An increase of hemoglobin (Hb) mass is the key target of blood doping practices to enhance performance as it is a main determinant of maximal oxygen uptake. Although detection methods exist for doping with recombinant EPO and homologous blood transfusions, autologous transfusions remain virtually undetectable. In this context, the most sensitive parameter would be a determination of Hb mass itself. The purpose therefore was to establish whether Hb mass measurements by the optimized CO-rebreathing method allow screening for the withdrawal and reinfusion of autologous red blood cells. The optimized CO-rebreathing method was used for evaluation of Hb mass in two groups at three time points (duplicate measurements: 1) baseline, 2) after donation, and 3) after reinfusion). Group I (N = 6) was to donate and receive 1 unit of packed red cells (PRC) in contrast to two PRC in group II (N = 4). The time span between withdrawal and reinfusion was 2 d. The mean Hb content of the blood units was 59.0 +/- 3.9 g (group I) and 108.3 +/- 1.3 g (group II). Hb mass decreased significantly after blood withdrawal (-89 +/- 16 g in group I and -120 +/- 14 g in group II) and increased significantly after reinfusion (group I: 70 +/- 16 g; group II: 90 +/- 9 g) but was lower than at baseline (group I: -19 +/- 17 g; group II: -30 +/- 14 g). The total error of measurements for the duplicate measures ranged between 0.8 and 3.1% (Hb mass: 6.4-22.1 g). Hb mass determination with the optimized CO-rebreathing method has sufficient precision to detect the absolute differences in Hb mass induced by blood withdrawal and autologous reinfusion. Thus, it may be suited to screen for artificially induced alterations in Hb mass.

1 December 2010 in International Journal of Sports Physiology and Performance
Verified
Journal Article
Closed access
PDF file
PSPhilo U. Saunders
Philo U. Saunders
CAChristoph Ahlgrim
Christoph Ahlgrim
BVBrent Vallance
Brent Vallance
DGDaniel J. Green
Daniel J. Green
EREileen Y. Robertson
Eileen Y. Robertson
CGChristopher J. Gore
Christopher J. Gore
Purpose: To quantify physiological and performance effects of hypoxic exposure, a training camp, the placebo effect, and a combination of these factors.Methods: Elite Australian and International race walkers (n= 17) were recruited, including men and women. Three groups were assigned: 1) Live High:Train Low (LHTL,n= 6) of 14 h/d at 3000 m simulated altitude; 2) Placebo (n= 6) of 14 h/d of normoxic exposure (600 m); and 3) Nocebo (n= 5) living in normoxia. All groups undertook similar training during the intervention. Physiological and performance measures included 10-min maximal treadmill distance, peak oxygen uptake (VO2peak), walking economy, and hemoglobin mass (Hbmass).Results: Blinding failed, so the Placebo group was a second control group aware of the treatment. All three groups improved treadmill performance by approx. 4%. Compared with Placebo, LHTL increased Hbmassby 8.6% (90% CI: 3.5 to 14.0%;P= .01, very likely), VO2peak by 2.7% (-2.2 to 7.9%;P= .34, possibly), but had no additional improvement in treadmill distance (-0.8%, -4.6 to 3.8%;P= .75, unlikely) or economy (-8.2%, -24.1 to 5.7%;P= .31, unlikely). Compared with Nocebo, LHTL increased Hbmassby 5.5% (2.5 to 8.7%;P= .01, very likely), VO2peak by 5.8% (2.3 to 9.4%;P= .02, very likely), but had no additional improvement in treadmill distance (0.3%, -1.9 to 2.5%;P= .75, possibly) and had a decrease in walking economy (-16.5%, -30.5 to 3.9%;P= .04, very likely).Conclusion: Overall, 3-wk LHTL simulated altitude training for 14 h/d increased Hbmassand VO2peak, but the improvement in treadmill performance was not greater than the training camp effect.